GenTealModerate to Severe (Novartis Pharmaceutical Corporation)


Welcome to the PulseAid listing for the GenTeal drug offered from Novartis Pharmaceutical Corporation. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Novartis Pharmaceutical Corporation
NON-PROPRIETARY NAME: hypromelloses and carboxymethylcellulose sodium
SUBSTANCE NAME: HYPROMELLOSES; CARBOXYMETHYLCELLULOSE SODIUM
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: OPHTHALMIC
DOSAGE FORM: GEL
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2009-09-14
END MARKETING DATE: 0000-00-00


GenTeal Moderate to Severe HUMAN OTC DRUG Details:

Item DescriptionGenTeal Moderate to Severe from Novartis Pharmaceutical Corporation
LABELER NAME: Novartis Pharmaceutical Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 3; 2.5(mg/mL; mg/mL)
START MARKETING DATE: 2009-09-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0078-0425_d84efbd9-c39a-3c0a-5918-2ed77f5cf4fb
PRODUCT NDC: 0078-0425
APPLICATION NUMBER: part349

Other HYPROMELLOSES; CARBOXYMETHYLCELLULOSE SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Novartis Pharmaceutical CorporationGenTeal